Leave a Reply

Next Post

Moderna prices new shares at $76, expects to raise $1.34 billion

Biotech company Moderna, which is testing one of the leading coronavirus vaccine candidates, priced an offering of 17.6 million new shares at $76 each, the company said late Monday. The company said it expects the offering to close around Thursday, with gross proceeds totaling around $1.34 billion. Moderna is also giving the […]